Beryllium Biobank 3: considerations for improving chronic beryllium disease screening

Area of Science:

• Occupational Health
• Immunotoxicology
• Medical Screening

Background:

• Beryllium exposure poses risks for developing beryllium sensitization (BeS) and chronic beryllium disease (CBD).
• Current screening protocols involve lymphocyte proliferation tests (LPTs) to identify individuals at risk.
• Accurate classification and timely detection of CBD are crucial for effective worker management.

Purpose of the Study:

• To optimize the screening process for beryllium-exposed workers.
• To evaluate the impact of different criteria for defining beryllium sensitization (BeS).
• To assess the cost-effectiveness of adjusted follow-up testing intervals for detecting chronic beryllium disease (CBD).

Main Methods:

• A simple binomial model was used to investigate the implications of defining BeS using two or more positive LPTs.
• A Markov model was employed to assess the effect of adjusting follow-up testing intervals for individuals with BeS.
• The study analyzed the accuracy and cost-effectiveness of different screening and testing strategies.

Main Results:

• Increased numbers of repeated LPTs reduce the accuracy of identifying BeS.
• Markov simulation demonstrated that personalized adjustments to second-stage screening intervals can significantly enhance cost-effectiveness.
• The findings highlight the trade-offs between testing frequency, diagnostic accuracy, and resource allocation.

Conclusions:

• Classification criteria for BeS should be adapted based on the number of LPTs conducted.
• Modifying follow-up testing intervals according to individual worker data can improve the cost-effectiveness of CBD detection.
• These adjustments are essential for efficient and accurate occupational health surveillance programs for beryllium exposure.